First, the quality of the PCOS GLP-1 evidence is generally moderate to low: trials are small, short, heterogeneous in design and comparator, and often use surrogate rather than hard reproductive endpoints, so even the class with actual PCOS data is not on firm regulatory footing for this use
Applications in Research: Chronic inflammation resolution models Skin, joint, and connective tissue regeneration Studies on gut permeability and barrier repair Anti-inflammatory and post-surgical recovery frameworks Combined angiogenesis and extracellular matrix signaling Storage & Handling: Store lyophilized powder at -20C in a light- and moisture-free environment
It has been investigated as a treatment for growth hormone deficiency and lipodystrophy, reaching phase II clinical trials that were discontinued for reasons unrelated to administration of the peptide
This data further suggests that GHRP-6 and Sermorelin may exert synergistic actions, although more data is needed to evaluate their potential as a blend in laboratory research